These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 8120404)

  • 1. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
    Giese T; Davidson WF
    J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr.
    Giese T; Davidson WF
    J Immunol; 1992 Nov; 149(9):3097-106. PubMed ID: 1383337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine secretion by C3H-lpr and -gld T cells. Hypersecretion of IFN-gamma and tumor necrosis factor-alpha by stimulated CD4+ T cells.
    Davidson WF; Calkins C; Hügins A; Giese T; Holmes KL
    J Immunol; 1991 Jun; 146(12):4138-48. PubMed ID: 1674953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of abnormal T cell development and autoimmunity in gld mice by transgenic T cell receptor beta chain.
    Yui K; Bhandoola A; Radic MZ; Komori S; Katsumata M; Greene MI
    Eur J Immunol; 1992 Jul; 22(7):1693-700. PubMed ID: 1385574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand.
    Sobel ES; Kakkanaiah VN; Kakkanaiah M; Cohen PL; Eisenberg RA
    J Immunol; 1995 Jan; 154(1):459-64. PubMed ID: 7527822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
    Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
    J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
    Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice.
    Mieza MA; Itoh T; Cui JQ; Makino Y; Kawano T; Tsuchida K; Koike T; Shirai T; Yagita H; Matsuzawa A; Koseki H; Taniguchi M
    J Immunol; 1996 May; 156(10):4035-40. PubMed ID: 8621946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.
    Bleesing JJ; Brown MR; Dale JK; Straus SE; Lenardo MJ; Puck JM; Atkinson TP; Fleisher TA
    Clin Immunol; 2001 Sep; 100(3):314-24. PubMed ID: 11513545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
    Sneller MC; Straus SE; Jaffe ES; Jaffe JS; Fleisher TA; Stetler-Stevenson M; Strober W
    J Clin Invest; 1992 Aug; 90(2):334-41. PubMed ID: 1386609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lpr T cells are necessary for autoantibody production in lpr mice.
    Sobel ES; Cohen PL; Eisenberg RA
    J Immunol; 1993 May; 150(9):4160-7. PubMed ID: 8473754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective T cells from gld mice play a pivotal role in development of Thy-1.2+B220+ cells and autoimmunity.
    Yasutomo K; Maeda K; Nagata S; Nagasawa H; Okada K; Good RA; Kuroda Y; Himeno K
    J Immunol; 1994 Dec; 153(12):5855-64. PubMed ID: 7527451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanded populations of CD4-CD8- T cell receptor alpha/beta+ T cells associated with the lpr and gld mutations are CD2-.
    Shirai T; Abe M; Yagita H; Okumura K; Morse HC; Davidson WF
    J Immunol; 1990 May; 144(10):3756-61. PubMed ID: 1970592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell specialization at environmental interfaces: T cells from the lung and the female genital tract of lpr and gld mice differ from their splenic and lymph node counterparts.
    Ibraghimov AR; Lynch RG
    Eur J Immunol; 1994 Aug; 24(8):1848-52. PubMed ID: 7519999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of the population of double negative CD4-8- T alpha beta-cells in the liver is a common feature of autoimmune mice.
    Masuda T; Ohteki T; Abo T; Seki S; Nose S; Nagura H; Kumagai K
    J Immunol; 1991 Nov; 147(9):2907-12. PubMed ID: 1833460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-restricted lymphoproliferation in autoimmune lpr mice.
    Matsuzawa A; Kimura M; Muraiso T; Kominami R; Katagiri T
    Eur J Immunol; 1991 Jun; 21(6):1535-42. PubMed ID: 2044659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the existence of two parallel differentiation pathways in the thymus of MRL lpr/lpr mice.
    Matsuzaki Y; Pannetien C; Kanagawa O; Gachelin G; Nakauchi H
    J Immunol; 1992 Aug; 149(3):1069-74. PubMed ID: 1378863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.